
Deborah Toppmeyer, MD
Advertisement
Articles by Deborah Toppmeyer, MD


ACR Appropriateness Criteria® Ductal Carcinoma in Situ
BySeth A. Kaufman, MD,Eleanor E. R. Harris, MD,Lisa Bailey, MD,Manjeet Chadha, MD,Sharon C. Dutton, MD,Gary M. Freedman, MD,Sharad Goyal, MD,Michele Y. Halyard, MD,Kathleen C. Horst, MD,Kristina L. M. Novick, MD,Catherine C. Park, MD,W. Warren Suh, MD,Deborah Toppmeyer, MD,Jennifer Zook, MD,Bruce G. Haffty, MD
Management of ductal carcinoma in situ (DCIS) commonly involves excision, radiotherapy, and hormonal therapy. Radiotherapy is employed for local control in breast conservation. Evidence is evolving for several radiotherapy techniques exist beyond standard whole-breast irradiation.

Management recommendations for breast cancer local-regional recurrence (LRR), including patient scenarios, are reviewed, and represent evidence-based data and expert opinion of the American College of Radiology Appropriateness Criteria Expert Panel on LRR.
Advertisement
Latest Updated Articles
ACR Appropriateness Criteria® Ductal Carcinoma in SituJune 15th 2015
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Imlunestrant Combo in ESR1-Mutated Breast Cancer
2
Fixed-Duration Combinations and MRD-Guided Therapy as Emerging Priorities in CLL
3
Japan Approves T-DXd Combo and Dato-DXd for First-Line Metastatic Breast Cancer
4
NCCN Guidelines Strengthen MRD Testing Recommendations in Multiple Myeloma
5